Page last updated: 2024-08-23

iso-sulfan blue and Atypical Ductal Hyperplasia

iso-sulfan blue has been researched along with Atypical Ductal Hyperplasia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cora, C; Deisch, J; Garberoglio, C; Garberoglio, R; Lum, SS; Olaya, W; Pairawan, SS; Senthil, M; Solomon, N1
Chung, A; Cody, H; Montgomery, L; Patil, S; Stempel, M; Yu, J1
Cox, CE; Kaur, P; Kiluk, JV; Laronga, C; Meade, T; Ramos, D; Santillan, AA1
Babiera, GV; Bedrosian, I; Hunt, KK; Hwang, RF; Kang, T; Kuerer, H; Lucci, A; Meric-Bernstam, F; Mittendorf, EA; Yi, M1
Afshari, S; Gur, I; Kilkenny, JW1
Chao, C; McMasters, K1
Blanchard, DK; Donohue, JH; Grant, CS; Reynolds, C1
Chua, B; Davis, N; Donald, JC; Hayashi, AH; Olivotto, IA; Rusnak, CH1
Chang, AE; Cimmino, VM; Degnim, AC; Diehl, KM; Newman, LA; Oh, K; Sabel, MS1
Bold, RJ; Fahy, BN; Schlieman, M1

Reviews

2 review(s) available for iso-sulfan blue and Atypical Ductal Hyperplasia

ArticleYear
The current status of sentinel lymph node biopsy for breast cancer.
    Advances in surgery, 2002, Volume: 36

    Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Lymph Node Excision; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2002
Sentinel lymph node biopsy for breast cancer.
    Cancer biotherapy & radiopharmaceuticals, 2001, Volume: 16, Issue:5

    Topics: Aged; Axilla; Bibliometrics; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Coloring Agents; Contraindications; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Mastectomy; Middle Aged; Neoplasm Staging; Patient Care Team; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2001

Trials

1 trial(s) available for iso-sulfan blue and Atypical Ductal Hyperplasia

ArticleYear
Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
    Annals of surgical oncology, 2016, Volume: 23, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Large-Core Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Coloring Agents; Female; Humans; Image-Guided Biopsy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid; Ultrasonography

2016

Other Studies

7 other study(ies) available for iso-sulfan blue and Atypical Ductal Hyperplasia

ArticleYear
Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
    Annals of surgical oncology, 2008, Volume: 15, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid

2008
Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy.
    Annals of surgical oncology, 2008, Volume: 15, Issue:12

    Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Feasibility Studies; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Morbidity; Neoplasm Invasiveness; Neoplasm Staging; Nipples; Postoperative Care; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Treatment Outcome

2008
Does blue dye contribute to success of sentinel node mapping for breast cancer?
    Annals of surgical oncology, 2010, Volume: 17 Suppl 3

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Nodes; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Young Adult

2010
Sudden false oxygen desaturation and factitious methemoglobinemia after subcutaneous injection of isosulfan blue (lymphazurin).
    The American surgeon, 2011, Volume: 77, Issue:3

    Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Cyanosis; Factitious Disorders; Female; Humans; Methemoglobinemia; Middle Aged; Oximetry; Rosaniline Dyes

2011
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.
    Archives of surgery (Chicago, Ill. : 1960), 2003, Volume: 138, Issue:5

    Topics: Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Immunohistochemistry; Logistic Models; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Middle Aged; Morbidity; Neoplasm Recurrence, Local; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2003
Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia.
    Canadian journal of surgery. Journal canadien de chirurgie, 2003, Volume: 46, Issue:4

    Topics: Breast Neoplasms; British Columbia; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Practice Patterns, Physicians'; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2003
Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
    Annals of surgical oncology, 2005, Volume: 12, Issue:9

    Topics: Axilla; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Humans; Lymph Nodes; Male; Radionuclide Imaging; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2005